Phosphorylation of merlin regulates its stability and tumor suppressive activity

Keqiang Ye1

  • 1Department of Pathology and Laboratory Medicine, Emory University School of Medicine, 615 Michael Street, Atlanta, Georgia 30322, USA. kye@emory.edu

Insights

The neurofibromatosis-2 (NF2) tumor suppressor, merlin, is degraded by Akt phosphorylation, creating a feedback loop that promotes tumor growth. This study reveals how Akt disrupts merlin

Area of Science:

  • Molecular Biology
  • Cell Biology
  • Oncology

Background:

  • Neurofibromatosis-2 (NF2) protein, merlin, suppresses tumor cell proliferation by interacting with proteins like CD44, ezrin, and PIKE.
  • Merlin's tumor-suppressive function relies on its folded conformation, regulated by phosphorylation by kinases such as PAK, PKA, and Akt.

Purpose of the Study:

  • To investigate the role of Akt in regulating merlin's conformation and function.
  • To elucidate the mechanism by which Akt influences merlin's stability and tumor suppressive activity.

Main Methods:

  • Phosphorylation site mapping of merlin by Akt.
  • Analysis of merlin's conformation and PIKE-L binding upon Akt-mediated phosphorylation.
  • Assessment of merlin ubiquitination and degradation pathways.
  • Investigation of the feedback loop involving merlin, PIKE-L, PI 3-kinase, and Akt.

Main Results:

  • Akt directly phosphorylates merlin at threonine 230 (T230) and serine 315 (S315).
  • This Akt-mediated phosphorylation destabilizes merlin's folded conformation, inhibits its binding to PIKE-L, and triggers its polyubiquitination and proteasomal degradation.
  • Merlin's proliferation-repressive activity is also modulated by S518 phosphorylation.
  • A negative feedback loop is established where Akt activation leads to merlin degradation, potentially promoting tumor growth.

Conclusions:

  • Akt-mediated phosphorylation of merlin at T230/S315 abrogates its tumor-suppressive function by promoting its degradation.
  • This mechanism, alongside S518 phosphorylation, offers insights into overcoming merlin inactivation in tumors.
  • Understanding this regulatory pathway is crucial for developing targeted cancer therapies.

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Phosphorylation01:02

Phosphorylation

The addition or removal of phosphate groups from proteins is the most common chemical modification that regulates cellular processes. These modifications can affect the structure, activity, stability, and localization of proteins within cells as well as their interactions with other proteins.
During phosphorylation, protein kinases transfer the terminal phosphate group of ATP to specific amino acid side chains of substrate proteins. Serine, threonine, and tyrosine are the most commonly...